Assignee
VANDA PHARMACEUTICALS INC
US·95 granted patents·95 pending applications·414 citations·filing 2006–2025
Top patents by PatentIndex Score
190 records- 0198US11324735B2Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·7 cites·13 claims
- 0298US11285129B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Mar 29, 2022·8 cites·3 claims
- 0398US10980770B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2020·Granted Apr 20, 2021·7 cites·12 claims
- 0498US8785492B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2013·Granted Jul 22, 2014·41 cites·5 claims
- 0597US12201604B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2024·Granted Jan 21, 2025·1 cites·9 claims
- 0697US11667718B2Cancer treatmentVANDA PHARMACEUTICALS INC·Filed 2021·Granted Jun 6, 2023·3 cites·10 claims
- 0797US10829465B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2020·Granted Nov 10, 2020·10 cites·20 claims
- 0897US10610510B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2018·Granted Apr 7, 2020·9 cites·13 claims
- 0997US9060995B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2014·Granted Jun 23, 2015·22 cites·1 claims
- 1096US12447141B2Liquid tasimelteon formulations and methods of use thereofVANDA PHARMACEUTICALS INC·Filed 2024·Granted Oct 21, 2025·1 cites·25 claims
- 1196US10653665B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2018·Granted May 19, 2020·8 cites·20 claims
- 1296US10463655B2Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2016·Granted Nov 5, 2019·8 cites·7 claims
- 1396US10149829B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2016·Granted Dec 11, 2018·13 cites·14 claims
- 1496US9549913B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2013·Granted Jan 24, 2017·18 cites·14 claims
- 1596US9539234B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2015·Granted Jan 10, 2017·15 cites·5 claims
- 1695US11759446B2Liquid tasimelteon formulations and methods of use thereofVANDA PHARMACEUTICALS INC·Filed 2021·Granted Sep 19, 2023·2 cites·14 claims
- 1795US11266622B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2020·Granted Mar 8, 2022·3 cites·7 claims
- 1895US10611744B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2018·Granted Apr 7, 2020·10 cites·9 claims
- 1995US9730910B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2014·Granted Aug 15, 2017·15 cites·5 claims
- 2094US11918556B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Mar 5, 2024·1 cites·3 claims
- 2194US11850229B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Dec 26, 2023·1 cites·3 claims
- 2294US11826339B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Nov 28, 2023·1 cites·4 claims
- 2394US11141400B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2020·Granted Oct 12, 2021·3 cites·10 claims
- 2494US11078289B2Cancer treatmentVANDA PHARMACEUTICALS INC·Filed 2019·Granted Aug 3, 2021·5 cites·9 claims
- 2594US10272076B2Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2017·Granted Apr 30, 2019·9 cites·20 claims
- 2694US10071977B2Highly purifid pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2015·Granted Sep 11, 2018·14 cites·24 claims
- 2794US7754902B2Ruthenium(II) catalysts for use in stereoselective cyclopropanationsVANDA PHARMACEUTICALS INC·Filed 2006·Granted Jul 13, 2010·37 cites·11 claims
- 2893US11918557B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2023·Granted Mar 5, 2024·1 cites·10 claims
- 2993US11760740B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2023·Granted Sep 19, 2023·1 cites·40 claims
- 3093US11737993B2Multiple myeloma treatmentVANDA PHARMACEUTICALS INC·Filed 2019·Granted Aug 29, 2023·3 cites·13 claims
- 3193US10449176B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2017·Granted Oct 22, 2019·5 cites·9 claims
- 3293US10179119B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2015·Granted Jan 15, 2019·10 cites·10 claims
- 3393US9138432B2Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2014·Granted Sep 22, 2015·12 cites·1 claims
- 3492US10987346B2Iloperidone for the treatment of schizophreniaVANDA PHARMACEUTICALS INC·Filed 2019·Granted Apr 27, 2021·4 cites·13 claims
- 3592US10610511B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2019·Granted Apr 7, 2020·8 cites·19 claims
- 3692US9855241B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·5 cites·9 claims
- 3791US11833130B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Dec 5, 2023·1 cites·10 claims
- 3891US11566011B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2021·Granted Jan 31, 2023·1 cites·5 claims
- 3991US10772880B2Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2019·Granted Sep 15, 2020·6 cites·13 claims
- 4091US10376487B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2014·Granted Aug 13, 2019·11 cites·20 claims
- 4191US10265282B2Cancer treatmentVANDA PHARMACEUTICALS INC·Filed 2018·Granted Apr 23, 2019·6 cites·10 claims
- 4290US11723903B2Treatment of schizophreniaVANDA PHARMACEUTICALS INC·Filed 2021·Granted Aug 15, 2023·1 cites·11 claims
- 4390US11633377B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Apr 25, 2023·1 cites·11 claims
- 4490US11607408B2Method of treatment of schizophreniaVANDA PHARMACEUTICALS INC·Filed 2020·Granted Mar 21, 2023·2 cites·23 claims
- 4590US10945988B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2019·Granted Mar 16, 2021·3 cites·13 claims
- 4690US2024342120A1Multiple myeloma treatmentVANDA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4790US2026007633A1Liquid Tasimelteon Formulations and Methods of Use ThereofVANDA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4889US12427132B2Method of improving sleepVANDA PHARMACEUTICALS INC·Filed 2022·Granted Sep 30, 2025·1 cites·10 claims
- 4989US10821099B2Use of tradipitant in motion sicknessVANDA PHARMACEUTICALS INC·Filed 2019·Granted Nov 3, 2020·5 cites·20 claims
- 5089US9458507B1Antipsychotic treatment based on SNP genotypeVANDA PHARMACEUTICALS INC·Filed 2016·Granted Oct 4, 2016·7 cites·12 claims
Showing the top 50 of 190 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →